Dallas-Fort Worth ranked 10th out of 250 cities for patent activity.Patents granted include: Alcon’s triple-lens intraocular lens system Berg treats cancer with continuous infusion of coenzyme Q10BLH Ecology Concepts’ nanoparticle production process CubicPV’s perovskite material processing IBM’s analysis and 3D printing-based prototype creation Made in USA by Lintek Artificial Muscle Actuator QORVO Advanced Antenna System Kit American Self-Driving Vehicle Control System
Left: US Patent No. 11,298,221 (Tri-Lens Intraocular Lens System) assigned to Alcon; Right: US Patent No. 11,303,009 (Packaging of Advanced Antenna System) assigned to Qorvo US, Inc.
Dallas Invents weekly reviews of US patents related to the Dallas-Fort Worth-Arlington metro area.The list includes patents granted to local assignees and/or North Texas inventors.Patent activity can be an indicator of future economic growth as well as emerging market development and talent attraction.By tracking inventors and assignees in the region, our goal is to provide a broader view of inventive activity in the region.The list is organized by Cooperative Patent Classification (CPC).
A: Human Necessities 14 B: Performing Operations; Transportation 8 C: Chemistry; Metallurgy 5 D: Textiles; Thesis 1 E: Fixed Structures 9 F: Mechanical Engineering; Lighting; Heating; Weapons; Demolition 3 G: Physics 37 H: Electricity 43
Texas Instruments Inc. (Dallas) 25 Bank of America Corporation (Charlotte, NC) 5 SanDisk Technologies LLC (Addison) 5 Textron Innovations Inc. (Providence, RI) 5 Halliburton Energy Services Inc. (Houston) 4 ATT Intellectual Property I LP ( Atlanta, GA) 3 PACCAR Inc. (Bellevue, WA) 3 Verizon Patent and Licensing Inc. (Basking Ridge, NJ) 3 Alcon Inc. (Fribourg, Switzerland) 2 Capital One Services, LLC (VA) McLean) 2
Christopher Aram Touraine (Fort Worth) 2 Eric Norman Tucker (Denton) 2 Louis Daniel Heilaneh (Lewisville) 2 Micah Price (Plano) 2
Don’t miss Dallas Invents: Sign up for the Dallas Innovates e-newsletter.Patent information provided by Joe Chiarella, founder of patent analysis firm Patent Index and publisher of The Inventiveness Index.
For more details on the patents granted below, please search the USPTO Patent Full Text and Image Database.
Inventor: F. William Gilmore (Parker, CO), Thomas C. Untermeyer (San Antonio, TX) Assignee: NATURAL SHRIMP INC. (Dallas, TX) Law Firm: No Attorney Application Number, Date, Speed: 2021 Jul 7, 17369434 (279 days to apply)
Abstract: Selected fresh or brackish water aquaculture systems are treated to automatically remove waste, ammonia and pathogens while controlling temperature, oxygen and feed amount for maximum growth and survival at maximum aquatic species densities.The core platform treatment technology removes ammonia by combining chlorine with ammonia to form chloramines, which are removed by catalytic activated carbon at downstream filter stations.The process also removes potential pathogens by sanitizing and energizing the water.The technology utilizes ammonia, chlorine, oxidation-reduction potential (ORP), and flow sensors to electronically regulate the amount of chlorine needed to remove existing ammonia.The control system utilizes temperature, dissolved oxygen and image processing sensors to optimize heating, cooling, feeding and aeration.
[A01K] Animal husbandry; caring for birds, fish, insects; fishing; raising or breeding animals, n.o.s.; new breeds of animals
Inventor: Sumant G. Krishnan (Dallas, Texas) Assignee: TAG Medical DevicesAgriculture Cooperative Ltd. (Kibbutz-Garden, Illinois) Law Firm: No Attorney Application Number, Date, Speed: 14485879 on 09 /15 /2014 (2766 days of app releases)
Abstract: A method of forming a channel in a bone, the method comprising: providing a first hole in the bone; and forming a second hole in the bone at a predetermined angle to the first hole, using the first hole as a A reference point for defining the location of the second hole in the bone where the first and second holes intersect.
Inventor: Vallabh Janardhan (Dallas, Texas) Assignee: Insera Therapeutics, Inc. (Sacramento, California) Law Firm: Knobbe Martens Olson Bear, LLP (12 non-local offices) Application No., Date, Velocity: 15903587 on February 23, 2018 (1509 days of app release)
Abstract: Vascular treatment devices and methods include a braided structure including a plurality of self-expandable bulbs, a hypotube, eg, a scattered pattern including multiple rows of longitudinally spaced incisions, and a braided structure and a hypotube between the braided structure and the hypotube. binding area.The braided structure may include a pattern of radiopaque filaments measurable under x-ray.The structure can be heat treated to include various shapes at different temperatures.The braided structure can be deployed for implantation in a blood vessel.The catheter may comprise a hypotube comprising a scattered pattern of longitudinally spaced rows of incisions and an optional balloon.The laser cutting system may include a fluid flow system.
[A61M] Devices for the introduction or introduction of media into the body (Introduction or introduction of media into the body of animals A61D 7/00; Devices for insertion of tampons A61F 13/26; Devices for oral administration of food or drugs A61J; containers for collection, storage or administration of blood or medicinal liquids A61J 1/05); devices for converting bodily media or removing media from the body (surgery A61B; chemical aspects of surgical items A61L; magnetic therapy using magnetic elements placed in the body A61N 2/10); producing or devices to end sleep or coma[5]
Connector Patent No. 11298158 for systems and methods for reducing the risk of proximal junctional kyphosis
Inventor: Michael O’Brien (Dallas, TX) Assignee: MEDOS INTERNATIONAL SARL (Le Locle, , CH) Law Firm: Barnes Thornburg LLP (local + 12 other cities) Application number, date, speed : 16584597 on September 26, 2019 (929 days to apply)
Abstract: Disclosed herein are systems and methods for reducing the risk of PJK, PJF, and other disorders.In some embodiments, longitudinal extensions may be added to the primary fixation construct to extend the construct to one or more additional vertebral levels.The extension may be attached to a first attachment point, such as the spinous process of the vertebra superior to the primary configuration.The extension may also be attached to a second attachment point, such as a component of the primary configuration or an anatomical structure disposed below the first attachment point.The extension may be more flexible and/or may limit movement to a lesser extent than the primary construct, thereby providing a more gradual transition from the instrumented vertebra to its adjacent natural patient anatomy.Extensions can be placed with little or no soft tissue disruption.
Inventors: Galen L. Smith (Allen, TX), Robert E. Jones (McKinney, TX) Assignee: Advanced Neuromodulation Systems, Inc. (Plano, TX) Law Firm: Norton Rose Fulbright US LLP (Local + 13 other subways) Application No., Date, Speed: 16265704 on February 1, 2019 (1166 days of application issued)
Abstract: A trajectory guidance device and one or more methods associated therewith for facilitating precise guided alignment and implantation of a DBS therapy device within a patient.The pivotable turntable is pivotally coupled to a base support and a vertical support operable to support a slider assembly arranged to receive an instrument column (IC) containing the treatment device .A first gimbal driver is disposed between the pivotable turntable and the base support, wherein the first gimbal driver is actuatable to cause a first pivotal movement of the slider assembly including the IC, the first pivotal movement Defined along a first arcuate path pivoting about a first arcuate path.The first pivot.A second gimbal driver is disposed between the pivotable turntable and the vertical support, wherein the second gimbal driver is actuatable to cause a second pivotal movement of the slider assembly including the IC, the second pivoting The rotational movement is defined along a second arcuate path pivoting about a second arcuate path.The second pivot axis is perpendicular to the first pivot axis.
Inventor: Philip Matthew McCulloch (Mansfield, TX) Assignee: Alcon Inc. (Fribourg, Switzerland) LLP: No Attorney Application Number, Date, Speed: 16716111 on December 16, 2019 (848 days) application release)
Abstract: The present disclosure provides a three-lens IOL system, including a first anterior lens, a second posterior lens, rigidly connected to the first lens through at least one rigid member, so that the second lens and the first lens are along a fixed distance axis, and the second lens and the first lens are along a fixed distance axis. Third, a central, movable lens, located between the first lens and the second lens, and adapted to move linearly forward in the direction of the first lens or backward in the direction of the second lens along an axis to change the optical focus The system, and the articulating actuator that contacts the movable lens and the capsular bag when the IOL system is implanted in the capsular bag, the articulating actuator is adapted to move the movable lens linearly along the axis.
[A61F] Implantable vascular filters; artificial limbs; devices that provide patency or prevent collapse of tubular structures of the body, such as stents; orthopaedic, nursing or contraceptive devices; heat packs; treatment or protection of the eyes or ears; bandages, dressings or Absorbent pad; first aid kit (denture A61C) [2006.01]
Inventor: John Patrick McCook (Frisco, TX) Assignee: Berg LLC (Framingham, MA) Law Firm: McCarter English, LLP (7 non-local offices) Application number, date , speed: 15869630 on 01/12/2018 (1551 days of app release)
Abstract: The present invention provides regimens and methods for treating cancer, including continuous infusion of coenzyme Q10.Coenzyme Q10 can be administered as monotherapy, or in combination with additional agents, such as anticancer, chemotherapeutic, or antiangiogenic agents.Coenzyme Q10 may be administered at two or more different rates.
[A61K] Preparations for medical, dental or toilet use (devices or methods specially adapted for the preparation of medicinal products into specific physical or administration forms; chemical aspects or materials for air deodorization, disinfection or sterilization A61J 3/00 Use, or for bandages, dressings, absorbent pads or surgical supplies A61L; soap composition C11D)
Inventor: Laura Montry (Colonial Texas) Assignee: Lorenol Laboratories, Inc. (Austin, Texas) Law Firm: Ferguson Braswell Fraser Kubasta PC (3 non-local offices) Application No., Date, Speed: 15965473 on April 27, 2018 (1446 days to apply)
Abstract: In various embodiments, skin treatments can be applied topically to improve skin health.Skin treatments can reduce inflammation, reduce redness, and/or reduce health time.The skin treatment agent may comprise a composition comprising two or more of [i] Brassica[/i] seed oil, bisabolol, and/or [i] ginger.[/A generation]
[A61K] Preparations for medical, dental or toilet use (devices or methods specially adapted for the preparation of medicinal products into specific physical or administration forms; chemical aspects or materials for air deodorization, disinfection or sterilization A61J 3/00 Use, or for bandages, dressings, absorbent pads or surgical supplies A61L; soap composition C11D)
Inventor: Andrew Nelson (Dallas, TX) Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt, Germany) Law Firm: Fish Richardson PC (local + 13 other cities) Application number, date, speed: 16336268 Posted on September 20, 2017 (1665 days to apply)
Abstract: The present disclosure relates to a drug delivery device.A drug delivery device includes a housing, a dispensing mechanism and an actuator.The housing has a first portion and a second portion.The dispensing mechanism includes a reservoir disposed in the housing.When the reservoir contains the drug, the dispensing mechanism is operable to dispense the drug from the reservoir.The first portion of the housing includes a distal end and the second portion is movable toward the distal end from an initial position to a ready position.When the second part is in the initial part, the dispensing mechanism becomes inoperable.When the second portion is in the ready position, the actuator is actuatable to operate the dispensing mechanism.
[A61M] Devices for the introduction or introduction of media into the body (Introduction or introduction of media into the body of animals A61D 7/00; Devices for insertion of tampons A61F 13/26; Devices for oral administration of food or drugs A61J; containers for collection, storage or administration of blood or medicinal liquids A61J 1/05); devices for converting bodily media or removing media from the body (surgery A61B; chemical aspects of surgical items A61L; magnetic therapy using magnetic elements placed in the body A61N 2/10); producing or devices to end sleep or coma[5]
Inventors: Jordan Duesman (Pilot Point, TX), Ni Zhu (Plano, TX), Thomas J. Shaw (Frisco, TX) Assignee: Retractable Technologies, Inc. (Little Elm, TX) Law Firm: Monty L Ross PLLC (Location not found) Application No., Date, Speed: 16286958 February 27, 2019 (1140 day application issued)
Abstract: A medical syringe having a selectively retractable needle and a multifunctional needle hub and retaining ring assembly including a needle hub having a head portion having a An inwardly tapering frustoconical portion of the fluid passageway, and a rearwardly facing annular surface surrounding the needle.A rear opening, and an elastomeric retaining ring with a substantially unexpanded collar extending rearward beyond the rearward facing annular surface to increase needle ejection force, reduce actuation force and improve fluid flow through the syringe.Also disclosed are annular protrusions on the interior of the retaining ring and on the exterior surface of the needle holder head.
[A61M] Devices for the introduction or introduction of media into the body (Introduction or introduction of media into the body of animals A61D 7/00; Devices for insertion of tampons A61F 13/26; Devices for oral administration of food or drugs A61J; containers for collection, storage or administration of blood or medicinal liquids A61J 1/05); devices for converting bodily media or removing media from the body (surgery A61B; chemical aspects of surgical items A61L; magnetic therapy using magnetic elements placed in the body A61N 2/10); producing or devices to end sleep or coma[5]
Inventor: David Fenyes (Southlake, TX) Assignee: Aktina Corp. (Congers, NY) Law Firm: Rothwell, Figg, Ernst Manbeck, PC (2 non-local offices) Application No., Date, Speed: 16934586 on 07/21/2020 (630 days to apply)
Abstract: The system for determining the isocenter of the LINAC includes equipment and procedures for determining the axis of rotation of the collimator, gantry, and patient couch.The system and device are able to track the translation-rotation of mechanical components connected to the LINAC to calculate the rotational axes of the gantry, collimator and table.Based on the data collected in relation to these axes, the LINAC isocenter is determined.The devices used in this system include a single transmitter module, a signal receiver module, and a positioning module.The system also includes an isocentric target module and a gravity module to determine LINAC’s gravity vector.
[A61N] Electrotherapy; Magnetic Therapy; Radiation Therapy; Ultrasound Therapy (Measurement of Bioelectricity A61B; Surgical Instruments, Devices or Methods for the Transmission of Non-Mechanical Forms of Energy to or from the Body A61B 18/00; General Anaesthesia Equipment A61M ; Incandescent lamp H01K; Infrared radiator for heating H05B ) [6]
Inventor: Lizette Warner (Arlington, TX) Assignee: KONINKLIJKE PHILIPS NV (Eindhoven, , NL) Law Firm: No Attorney Application Number, Date, Speed: 16096317 April 17, 2017 (1821 day application issued)
Abstract: It is an object of the present invention to improve quality assurance when using MRI images for radiation therapy planning.This object is achieved by configuring a treatment plan evaluation tool A for calculating quality indicators of radiation therapy treatment plans.Radiation therapy plans are derived from planning images, which are MRI images acquired in the presence of a main magnetic field with magnetic field inhomogeneities.The treatment plan evaluation tool is further configured to receive information regarding magnetic field inhomogeneity, and the treatment plan evaluation tool is further configured to calculate a quality indicator based on the information regarding magnetic field homogeneity.
[A61N] Electrotherapy; Magnetic Therapy; Radiation Therapy; Ultrasound Therapy (Measurement of Bioelectricity A61B; Surgical Instruments, Devices or Methods for the Transmission of Non-Mechanical Forms of Energy to or from the Body A61B 18/00; General Anaesthesia Equipment A61M ; Incandescent lamp H01K; Infrared radiator for heating H05B ) [6]
Inventor: Scott Rollin Michael Schmitz (Lewisville, TX) Assignee: TRAXXAS, LP (McKinney, TX) Law Firm: No Counsel Application Number, Date, Speed: 16343386 Applied on October 19, 2017 (1636 days) program release)
Abstract: An apparatus, system and method for connecting auxiliary equipment to a model vehicle are provided.The device includes an accessory port that connects to an electronic speed controller and an accessory connector that connects to auxiliary equipment.The system also includes battery and accessory ports that connect to the electronic speed controller.Accessory connectors that connect to auxiliary devices are designed to connect to accessory ports.An electronic speed controller provides control for auxiliary equipment.The method includes providing an electronic speed controller connected to the accessory port and connecting the accessory connector to the accessory port.Accessory connectors are further connected to auxiliary equipment.The method also includes attaching the auxiliary device to the model vehicle and controlling the auxiliary device through the electronic speed controller.
Inventor: Isador Harry Lieberman (Plano, Texas) Assignee: AGADA MEDICAL LTD. (Kfar Vitkin, , IL) Law Firm: Venable LLP (7 non-local offices) Application No., Date, Speed: 16506504 on July 9, 2019 (1008 days to apply)
Abstract: According to some embodiments of the present invention, an intervertebral disc replacement includes a first layer having a first layer for contacting an inferior surface of a first vertebra, a second layer coupled to the first layer, the second layer including a plurality of compressible column springs, And the third layer is coupled to the second layer, the third layer has an upper surface for contacting the second vertebra.Each of the plurality of compressible cylindrical springs includes a plurality of stacked coils, and each of the plurality of stacked coils has a spring constant (K).At least one of the plurality of compressible column springs includes a first coil having a first spring constant and a second coil including a second spring constant, wherein the first spring constant is different from the second spring constant.
[A61F] Implantable vascular filters; artificial limbs; devices that provide patency or prevent collapse of tubular structures of the body, such as stents; orthopaedic, nursing or contraceptive devices; heat packs; treatment or protection of the eyes or ears; bandages, dressings or Absorbent pad; first aid kit (denture A61C) [2006.01]
Inventors: John E. Lott (Weatherford, TX), Richard Francis Reidy (Denton, TX) Assignee: BLH ECOLOGY CONCEPTS, LLC (Toral, TX) Law Firm: Renner, Otto, Boisselle Sklar, LLP (1 non-local office) Application number, date, speed: 11/08/2018 16762168 (1251 days for application issued)
Abstract: A method of producing nanoparticles of a substance, comprising, in a first chamber, forming a dispersion of a substance in a fluid, and causing the fluid to enter a supercritical state; passing the dispersion from the first chamber through a cooling device or into a second chamber a cooling zone in the chamber, wherein the cooling device or cooling zone is configured to reduce the temperature of the dispersion below the temperature at which the fluid forms solid particles, so that a substance is formed, wherein the second chamber comprises solid particles and a substance of the substance configured to receive the fluid the surface of the nanoparticles; reducing the pressure and/or increasing the temperature in the second chamber to convert the solid particles to a gaseous state, removing the fluid in the gaseous state and the nanoparticles remaining on the surface; and collecting the nanoparticles from the surface.
[B01J] Chemical or physical processes, such as catalysis, colloidal chemistry; their associated equipment (for processes or equipment used in specific applications, see the relevant location for these processes or equipment, e.g. F26B 3/08)[2]
Post time: May-23-2022
